[Retracted] mRNA-Modified FUS/NRF2 Signalling Inhibits Ferroptosis and Promotes Prostate Cancer Growth

<div>Effects of Erastin, ferroptosis inhibitor, and FUS knockdown on GPX4 and P53 expression. (a) P53 expression in LNCaP cells after treatment. (b) P53 expression in C42 cells after treatment. (c) GPX4 expression in LNCaP cells after treatment. (d) GPX4 expression in C42 cells after treatment.</div>

Computational and Mathematical Methods in Medicine

fig5

Figure 5

Figure 5: [Retracted] mRNA-Modified FUS/NRF2 Signalling Inhibits Ferroptosis and Promotes Prostate Cancer Growth 